BMRN
USDBioMarin Pharmaceutical Inc. Common Stock
السعر في الوقت الحقيقي
مخطط الأسعار
المقاييس الرئيسية
مقاييس السوق
الافتتاح
$52.560
الأعلى
$52.760
الأدنى
$51.800
الحجم
2.96M
أساسيات الشركة
القيمة السوقية
10.1B
الصناعة
التكنولوجيا الحيوية
البلد
United States
إحصاءات التداول
متوسط الحجم
2.34M
البورصة
NMS
العملة
USD
نطاق 52 أسبوعاً
أخبار ذات صلة
Bernstein Maintains Outperform on BioMarin Pharmaceutical, Lowers Price Target to $88
Bernstein analyst William Pickering maintains BioMarin Pharmaceutical with a Outperform and lowers the price target from $95 to $88.
Truist Securities Maintains Buy on BioMarin Pharmaceutical, Lowers Price Target to $80
Truist Securities analyst Joon Lee maintains BioMarin Pharmaceutical with a Buy and lowers the price target from $90 to $80.
Wells Fargo Maintains Overweight on BioMarin Pharmaceutical, Lowers Price Target to $70
Wells Fargo analyst Mohit Bansal maintains BioMarin Pharmaceutical with a Overweight and lowers the price target from $90 to $70.
Barclays Maintains Overweight on BioMarin Pharmaceutical, Lowers Price Target to $80
Barclays analyst Gena Wang maintains BioMarin Pharmaceutical with a Overweight and lowers the price target from $86 to $80.
HC Wainwright & Co. Maintains Neutral on BioMarin Pharmaceutical, Lowers Price Target to $55
HC Wainwright & Co. analyst Mitchell S. Kapoor maintains BioMarin Pharmaceutical with a Neutral and lowers the price target from $60 to $55.
Morgan Stanley Maintains Overweight on BioMarin Pharmaceutical, Lowers Price Target to $98
Morgan Stanley analyst Matthew Harrison maintains BioMarin Pharmaceutical with a Overweight and lowers the price target from $104 to $98.
BioMarin Reports Third Quarter 2025 Results and Provides Corporate Update
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced financial results for the third quarter ended September 30, 2025. "We are pleased with...
أسهم ذات صلة
ابق على اطلاع
تعيين تنبيهات الأسعار، الحصول على تحديثات تحليل الذكاء الاصطناعي وأخبار السوق في الوقت الحقيقي.